Acquiring Company
Intellia Therapeutics, Inc.
Acquired Company
Intellia Therapeutics, Inc.
CambridgeCambridgeBiotechnologyData And AnalyticsHealth CareScience And EngineeringBiotechnologyData And AnalyticsHealth CareScience And EngineeringDescription
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing curative therapeutics leveraging CRISPR-based technologies, today announced the acquisition of Rewrite Therapeutics, Inc. (Rewrite), a private biotechnology company focused on advancing novel DNA writing technologies.
Quick answer
Intellia Therapeutics, Inc. is acquiring Intellia Therapeutics, Inc., announced February 3, 2022. Intellia Therapeutics, Inc. is based in Cambridge, Massachusetts, United States.
- Who acquired Intellia Therapeutics, Inc?
- Intellia Therapeutics, Inc. agreed to acquire Intellia Therapeutics, Inc. on February 3, 2022.
- How much did Intellia Therapeutics, Inc. pay for Intellia Therapeutics, Inc?
- The deal value was not disclosed.
- Where are Intellia Therapeutics, Inc. and Intellia Therapeutics, Inc. based?
- Intellia Therapeutics, Inc. is based in Cambridge, Massachusetts, United States. Intellia Therapeutics, Inc. is based in Cambridge, Massachusetts, United States.
- Who are the decision-makers at Intellia Therapeutics, Inc?
- Fundz holds 1 contact at Intellia Therapeutics, Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Data And Analytics and Science And Engineering
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Element Biosciences Closes Acquisition Of Loop Genomics (February 8, 2022)
- Emmes Acquires Casimir, Its Fourth Major Acquisition (March 10, 2022)
- Glooko Acquires Germany-Based Xbird, A Medical Ai Company (January 31, 2022)
- G2 Acquires Lophos Pharma, A Peyote Focused Psychedelics Company (January 21, 2022)
- Medtronic To Acquire Affera (January 10, 2022)
- Trella Health Acquires Playmaker Health (January 4, 2022)
Who to call at Intellia Therapeutics, Inc., and when
When Intellia Therapeutics, Inc. changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Intellia Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Intellia Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Intellia Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Intellia Therapeutics, Inc. makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. was acquired by Intellia Therapeutics, Inc., based in Cambridge. The deal was reported on February 3, 2022. Intellia Therapeutics was formed in 2014 to lead the industry in one of the most promising new areas of therapeutic development Intellia Therapeutics, Inc. is publicly traded (NTLA) and operates in Biotechnology.
When did Intellia Therapeutics, Inc. acquire Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc.'s acquisition of Intellia Therapeutics, Inc. was reported on February 3, 2022. Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing curative therapeutics leveraging CRISPR-based technologies, today announced the acquisition of Rewrite Therapeutics, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Intellia Therapeutics, Inc. do?
Intellia Therapeutics was formed in 2014 to lead the industry in one of the most promising new areas of therapeutic development It is publicly traded (NTLA), operating in Biotechnology, and is based in Cambridge.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.